BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma JL, Jin L, Li YD, He CC, Guo XJ, Liu R, Yang YY, Han SX. The intensity of radiotherapy-elicited immune response is associated with esophageal cancer clearance. J Immunol Res. 2014;2014:794249. [PMID: 24967419 DOI: 10.1155/2014/794249] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Qiu H, Song H, Luo M, Ke S, Shi W, Chen J, Zhao W, Luo H, Chen Y. Dysfunction of apoptosis and autophagy correlates with local recurrence in esophageal squamous cell carcinoma after definitive chemoradiation. Cancer Cell Int 2021;21:466. [PMID: 34488754 DOI: 10.1186/s12935-021-02171-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Anciaux M, Demetter P, De Wind R, Gomez Galdon M, Vande Velde S, Lens G, Craciun L, Deleruelle A, Larsimont D, Lenaerts T, Sclafani F, Deleporte A, Donckier V, Hendlisz A, Vandeputte C. Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer. BMJ Open Gastroenterol 2020;7:e000431. [PMID: 32675198 DOI: 10.1136/bmjgast-2020-000431] [Reference Citation Analysis]
3 Kotsafti A, Scarpa M, Cavallin F, Fassan M, Salmaso R, Porzionato A, Saadeh L, Cagol M, Alfieri R, Castoro C, Rugge M, Castagliuolo I, Scarpa M. Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete response. Oncoimmunology 2020;9:1804169. [PMID: 32923165 DOI: 10.1080/2162402X.2020.1804169] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Chen MX, Liu YM, Li Y, Yang X, Wei WB. Elevated VEGF-A & PLGF concentration in aqueous humor of patients with uveal melanoma following Iodine-125 plaque radiotherapy. Int J Ophthalmol 2020;13:599-605. [PMID: 32399411 DOI: 10.18240/ijo.2020.04.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Wang XB, Wu DJ, Chen WP, Liu J, Ju YJ. Impact of radiotherapy on immunological parameters, levels of inflammatory factors, and clinical prognosis in patients with esophageal cancer. J Radiat Res 2019;60:353-63. [PMID: 31034571 DOI: 10.1093/jrr/rrz006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
6 Lierova A, Jelicova M, Nemcova M, Proksova M, Pejchal J, Zarybnicka L, Sinkorova Z. Cytokines and radiation-induced pulmonary injuries. J Radiat Res 2018;59:709-53. [PMID: 30169853 DOI: 10.1093/jrr/rry067] [Cited by in Crossref: 15] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
7 Liao D, Jia C, Sun P, Qi J, Li X. Quality evaluation of Panax quinquefolium from different cultivation regions based on their ginsenoside content and radioprotective effects on irradiated mice. Sci Rep 2019;9:1079. [PMID: 30705366 DOI: 10.1038/s41598-018-37959-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
8 Goedegebuure RSA, de Klerk LK, Bass AJ, Derks S, Thijssen VLJL. Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer? Front Immunol 2018;9:3107. [PMID: 30692993 DOI: 10.3389/fimmu.2018.03107] [Cited by in Crossref: 32] [Cited by in F6Publishing: 50] [Article Influence: 10.7] [Reference Citation Analysis]
9 Beschel LM, Leu M, Reichardt SD, Rave-Fränk M, Schirmer MA, Stadelmann C, Canis M, Wolff HA, Reichardt HM. T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer. Oncotarget 2016;7:65902-15. [PMID: 27589568 DOI: 10.18632/oncotarget.11677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Yang ZR, Zhao N, Meng J, Shi ZL, Li BX, Wu XW, Li P, Zhang Q, Wei XB, Fu S. Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes. Oncotarget 2016;7:26422-35. [PMID: 27029063 DOI: 10.18632/oncotarget.8389] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
11 Qiao YM, Zhang Y. Immunotherapy for esophageal cancer: Current studies and future perspectives. Shijie Huaren Xiaohua Zazhi 2016; 24(36): 4739-4751 [DOI: 10.11569/wcjd.v24.i36.4739] [Reference Citation Analysis]
12 Shahid S. Review of hematological indices of cancer patients receiving combined chemotherapy & radiotherapy or receiving radiotherapy alone. Crit Rev Oncol Hematol 2016;105:145-55. [PMID: 27423975 DOI: 10.1016/j.critrevonc.2016.06.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
13 Rahman M, Lovat F, Romano G, Calore F, Acunzo M, Bell EH, Nana-Sinkam P. miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung. J Biol Chem. 2014;289:26406-26416. [PMID: 25092292 DOI: 10.1074/jbc.m114.573592] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 5.5] [Reference Citation Analysis]